Skip to main content
Top
Published in: BMC Psychiatry 1/2012

Open Access 01-12-2012 | Research article

The generalizability of psychotherapy efficacy trials in major depressive disorder: an analysis of the influence of patient selection in efficacy trials on symptom outcome in daily practice

Authors: Rosalind van der Lem, Wouter WH de Wever, Nic JA van der Wee, Tineke van Veen, Pim Cuijpers, Frans G Zitman

Published in: BMC Psychiatry | Issue 1/2012

Login to get access

Abstract

Background

Treatment guidelines for major depressive disorder (MDD) are based on results from randomized clinical trials, among others in psychotherapy efficacy trials. However, patients in these trials differ from routine practice patients since trials use stringent criteria for patient selection. It is unknown whether the exclusion criteria used in psychotherapy efficacy trials (PETs) influence symptom outcome in clinical practice. We first explored which exclusion criteria are used in PETs. Second, we investigated the influence of commonly used exclusion criteria on symptom outcome in routine clinical practice.

Methods

We performed an extensive literature search in PubMed, PsycInfo and additional databases for PETs for MDD. From these, we identified commonly used exclusion criteria. We investigated the influence of exclusion criteria on symptom outcome by multivariate regression models in a sample of patients suffering from MDD according to the MINIplus from a routine clinical practice setting (n=598). Data on routine clinical practice patients were gathered through Routine Outcome Monitoring.

Results

We selected 20 PETs and identified the following commonly used exclusion criteria: ‘a baseline severity threshold of HAM-D≤14’, ‘current or past abuse or dependence of alcohol and/or drugs’ and ‘previous use of medication or ECT’. In our routine clinical practice sample of patients suffering from MDD (n=598), presence of ‘current or past abuse of or dependence on alcohol and/or drugs’ had no significant influence on outcome.‘Meeting a baseline severity threshold of HAM-D≤14’ and ‘previous use of medication or ECT’ were associated with better outcome, but the explained variance of the models was very small (R2=2-11%).

Conclusions

The most consistently used exclusion criteria are not a major threat to the generalizability of results found in PETs. However, PETs do somewhat improve their results by exclusion of patients with minor depression and patients who used antidepressants prior to psychotherapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimmerman M, Mattia JI, Posternak MA: Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry. 2002, 159: 469-473. 10.1176/appi.ajp.159.3.469.CrossRefPubMed Zimmerman M, Mattia JI, Posternak MA: Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry. 2002, 159: 469-473. 10.1176/appi.ajp.159.3.469.CrossRefPubMed
2.
go back to reference Zimmerman M, Chelminski I, Posternak MA: Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. J Nerv Ment Dis. 2004, 192: 87-94. 10.1097/01.nmd.0000110279.23893.82.CrossRefPubMed Zimmerman M, Chelminski I, Posternak MA: Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. J Nerv Ment Dis. 2004, 192: 87-94. 10.1097/01.nmd.0000110279.23893.82.CrossRefPubMed
3.
go back to reference Zetin M, Hoepner CT: Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007, 27: 295-301. 10.1097/JCP.0b013e318058263f.CrossRefPubMed Zetin M, Hoepner CT: Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007, 27: 295-301. 10.1097/JCP.0b013e318058263f.CrossRefPubMed
4.
go back to reference Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003, 290: 1624-1632. 10.1001/jama.290.12.1624.CrossRefPubMed Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003, 290: 1624-1632. 10.1001/jama.290.12.1624.CrossRefPubMed
5.
go back to reference Wells KB: Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999, 156: 5-10.CrossRefPubMed Wells KB: Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999, 156: 5-10.CrossRefPubMed
6.
go back to reference Partonen T, Sihvo S, Lonnqvist JK: Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry. 1996, 57: 572-575. 10.4088/JCP.v57n1203.CrossRefPubMed Partonen T, Sihvo S, Lonnqvist JK: Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry. 1996, 57: 572-575. 10.4088/JCP.v57n1203.CrossRefPubMed
7.
go back to reference van der Lem R, van der Wee NJ, Van VT, Zitman FG: The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2011, 41: 1353-1363. 10.1017/S0033291710002175.CrossRefPubMed van der Lem R, van der Wee NJ, Van VT, Zitman FG: The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2011, 41: 1353-1363. 10.1017/S0033291710002175.CrossRefPubMed
8.
go back to reference Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, et al: Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009, 166: 599-607. 10.1176/appi.ajp.2008.08071027.CrossRefPubMed Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, et al: Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009, 166: 599-607. 10.1176/appi.ajp.2008.08071027.CrossRefPubMed
9.
go back to reference Lem R, Stamsnieder P, Wee N, Veen T, Zitman FG: Socio-demographic features in randomized controlled trials for major depression: generalizability and individualization. Int J Person Cent Medicine. 2011, 1: 268-278. Lem R, Stamsnieder P, Wee N, Veen T, Zitman FG: Socio-demographic features in randomized controlled trials for major depression: generalizability and individualization. Int J Person Cent Medicine. 2011, 1: 268-278.
10.
go back to reference Stirman SW, Derubeis RJ, Crits-Christoph P, Rothman A: Can the randomized controlled trial literature generalize to nonrandomized patients?. J Consult Clin Psychol. 2005, 73: 127-135.CrossRefPubMed Stirman SW, Derubeis RJ, Crits-Christoph P, Rothman A: Can the randomized controlled trial literature generalize to nonrandomized patients?. J Consult Clin Psychol. 2005, 73: 127-135.CrossRefPubMed
11.
go back to reference Stirman SW, Derubeis RJ, Crits-Christoph P, Brody PE: Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. J Consult Clin Psychol. 2003, 71: 963-972.CrossRefPubMed Stirman SW, Derubeis RJ, Crits-Christoph P, Brody PE: Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. J Consult Clin Psychol. 2003, 71: 963-972.CrossRefPubMed
12.
go back to reference de Beurs E, den Hollander-Gijsman ME, van Rood YR, van der Wee NJ, Giltay EJ, van Noorden MS, et al: Routine outcome monitoring in the Netherlands: practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice. Clin Psychol Psychother. 2011, 18: 1-12. 10.1002/cpp.696.CrossRefPubMed de Beurs E, den Hollander-Gijsman ME, van Rood YR, van der Wee NJ, Giltay EJ, van Noorden MS, et al: Routine outcome monitoring in the Netherlands: practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice. Clin Psychol Psychother. 2011, 18: 1-12. 10.1002/cpp.696.CrossRefPubMed
13.
go back to reference Karasu T, Gelenberg AJ, Merriam A, Wang P: Practice guidelines for the treatment of patients with major depressive disorder. 2000, American Psychiatric Association, Second Karasu T, Gelenberg AJ, Merriam A, Wang P: Practice guidelines for the treatment of patients with major depressive disorder. 2000, American Psychiatric Association, Second
14.
go back to reference Anderson I, Pilling S, Barnes A, Bayliss L, Bird V: The NICE guideline on the treatment and management of depression in adults. London: The British Psychological Society & The Royal College of Psychiatrists, Updated version 2010. 1-1-2009 Anderson I, Pilling S, Barnes A, Bayliss L, Bird V: The NICE guideline on the treatment and management of depression in adults. London: The British Psychological Society & The Royal College of Psychiatrists, Updated version 2010. 1-1-2009
15.
go back to reference National Taskforce Guideline: Multidisciplinary guidelines for diagnostics and treatment of adult patients with major depressive disorder. The Netherlands: Stuurgroep Richtlijnen/ Trimbos Institute, revised version. 1-1-2005 National Taskforce Guideline: Multidisciplinary guidelines for diagnostics and treatment of adult patients with major depressive disorder. The Netherlands: Stuurgroep Richtlijnen/ Trimbos Institute, revised version. 1-1-2005
16.
go back to reference Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 20 (59 Suppl): 22-33. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 20 (59 Suppl): 22-33.
17.
go back to reference Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G: A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl. 1978, 5-27. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G: A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl. 1978, 5-27.
18.
go back to reference Posternak MA, Zimmerman M, Keitner GI, Miller IW: A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am J Psychiatry. 2002, 159: 191-200. 10.1176/appi.ajp.159.2.191.CrossRefPubMed Posternak MA, Zimmerman M, Keitner GI, Miller IW: A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am J Psychiatry. 2002, 159: 191-200. 10.1176/appi.ajp.159.2.191.CrossRefPubMed
19.
go back to reference Lem R, Wee N, Veen T, Zitman FG: The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2010 Lem R, Wee N, Veen T, Zitman FG: The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2010
20.
go back to reference Zimmerman M, Chelminski I, Posternak M: A review of studies of the montgomery-asberg depression rating scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol. 2004, 19: 1-7. 10.1097/00004850-200401000-00001.CrossRefPubMed Zimmerman M, Chelminski I, Posternak M: A review of studies of the montgomery-asberg depression rating scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol. 2004, 19: 1-7. 10.1097/00004850-200401000-00001.CrossRefPubMed
21.
go back to reference McLean PD, Hakstian AR: Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol. 1979, 47: 818-836.CrossRefPubMed McLean PD, Hakstian AR: Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol. 1979, 47: 818-836.CrossRefPubMed
22.
go back to reference Gardner P, Oei TP: Depression and self-esteem: an investigation that used behavioral and cognitive approaches to the treatment of clinically depressed clients. J Clin Psychol. 1981, 37: 128-135. 10.1002/1097-4679(198101)37:1<128::AID-JCLP2270370124>3.0.CO;2-1.CrossRefPubMed Gardner P, Oei TP: Depression and self-esteem: an investigation that used behavioral and cognitive approaches to the treatment of clinically depressed clients. J Clin Psychol. 1981, 37: 128-135. 10.1002/1097-4679(198101)37:1<128::AID-JCLP2270370124>3.0.CO;2-1.CrossRefPubMed
23.
go back to reference Garvey MJ, Hollon SD, Derubeis RJ: Do depressed patients with higher pretreatment stress levels respond better to cognitive therapy than imipramine?. J Affect Disord. 1994, 32: 45-50. 10.1016/0165-0327(94)90060-4.CrossRefPubMed Garvey MJ, Hollon SD, Derubeis RJ: Do depressed patients with higher pretreatment stress levels respond better to cognitive therapy than imipramine?. J Affect Disord. 1994, 32: 45-50. 10.1016/0165-0327(94)90060-4.CrossRefPubMed
24.
go back to reference Kovacs M, Rush AJ, Beck AT, Hollon SD: Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Arch Gen Psychiatry. 1981, 38: 33-39. 10.1001/archpsyc.1981.01780260035003.CrossRefPubMed Kovacs M, Rush AJ, Beck AT, Hollon SD: Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Arch Gen Psychiatry. 1981, 38: 33-39. 10.1001/archpsyc.1981.01780260035003.CrossRefPubMed
25.
go back to reference Simons AD, Garfield SL, Murphy GE: The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. Arch Gen Psychiatry. 1984, 41: 45-51. 10.1001/archpsyc.1984.01790120049007.CrossRefPubMed Simons AD, Garfield SL, Murphy GE: The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. Arch Gen Psychiatry. 1984, 41: 45-51. 10.1001/archpsyc.1984.01790120049007.CrossRefPubMed
26.
go back to reference Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, et al: Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1991, 148: 997-1008.CrossRefPubMed Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, et al: Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1991, 148: 997-1008.CrossRefPubMed
27.
go back to reference Weissman MM, Prusoff BA, DiMascio A, Neu C, Goklaney M, Klerman GL: The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry. 1979, 136: 555-558.PubMed Weissman MM, Prusoff BA, DiMascio A, Neu C, Goklaney M, Klerman GL: The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry. 1979, 136: 555-558.PubMed
28.
go back to reference Beck AT, Hollon SD, Young JE, Bedrosian RC, Budenz D: Treatment of depression with cognitive therapy and amitriptyline. Arch Gen Psychiatry. 1985, 42: 142-148. 10.1001/archpsyc.1985.01790250036005.CrossRefPubMed Beck AT, Hollon SD, Young JE, Bedrosian RC, Budenz D: Treatment of depression with cognitive therapy and amitriptyline. Arch Gen Psychiatry. 1985, 42: 142-148. 10.1001/archpsyc.1985.01790250036005.CrossRefPubMed
29.
go back to reference Blackburn IM, Bishop S, Glen AI, Whalley LJ, Christie JE: The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry. 1981, 139: 181-189. 10.1192/bjp.139.3.181.CrossRefPubMed Blackburn IM, Bishop S, Glen AI, Whalley LJ, Christie JE: The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry. 1981, 139: 181-189. 10.1192/bjp.139.3.181.CrossRefPubMed
30.
go back to reference Blom MB, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, et al: Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom. 2007, 76: 289-297. 10.1159/000104705.CrossRefPubMed Blom MB, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, et al: Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom. 2007, 76: 289-297. 10.1159/000104705.CrossRefPubMed
31.
go back to reference Derubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al: Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005, 62: 409-416. 10.1001/archpsyc.62.4.409.CrossRefPubMed Derubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al: Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005, 62: 409-416. 10.1001/archpsyc.62.4.409.CrossRefPubMed
32.
go back to reference DiMascio A, Weissman MM, Prusoff BA, Neu C, Zwilling M, Klerman GL: Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry. 1979, 36: 1450-1456. 10.1001/archpsyc.1979.01780130068008.CrossRefPubMed DiMascio A, Weissman MM, Prusoff BA, Neu C, Zwilling M, Klerman GL: Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry. 1979, 36: 1450-1456. 10.1001/archpsyc.1979.01780130068008.CrossRefPubMed
33.
go back to reference Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al: Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006, 74: 658-670.CrossRefPubMed Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al: Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006, 74: 658-670.CrossRefPubMed
34.
go back to reference Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, et al: National institute of mental health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry. 1989, 46: 971-982. 10.1001/archpsyc.1989.01810110013002.CrossRefPubMed Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, et al: National institute of mental health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry. 1989, 46: 971-982. 10.1001/archpsyc.1989.01810110013002.CrossRefPubMed
35.
go back to reference Hollon SD, Derubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, et al: Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry. 1992, 49: 774-781. 10.1001/archpsyc.1992.01820100018004.CrossRefPubMed Hollon SD, Derubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, et al: Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry. 1992, 49: 774-781. 10.1001/archpsyc.1992.01820100018004.CrossRefPubMed
36.
go back to reference Luty SE, Carter JD, McKenzie JM, Rae AM, Frampton CM, Mulder RT, et al: Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry. 2007, 190: 496-502. 10.1192/bjp.bp.106.024729.CrossRefPubMed Luty SE, Carter JD, McKenzie JM, Rae AM, Frampton CM, Mulder RT, et al: Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry. 2007, 190: 496-502. 10.1192/bjp.bp.106.024729.CrossRefPubMed
37.
go back to reference McBride C, Atkinson L, Quilty LC, Bagby RM: Attachment as moderator of treatment outcome in major depression: a randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. J Consult Clin Psychol. 2006, 74: 1041-1054.CrossRefPubMed McBride C, Atkinson L, Quilty LC, Bagby RM: Attachment as moderator of treatment outcome in major depression: a randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. J Consult Clin Psychol. 2006, 74: 1041-1054.CrossRefPubMed
38.
go back to reference Murphy GE, Simons AD, Wetzel RD, Lustman PJ: Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry. 1984, 41: 33-41. 10.1001/archpsyc.1984.01790120037006.CrossRefPubMed Murphy GE, Simons AD, Wetzel RD, Lustman PJ: Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry. 1984, 41: 33-41. 10.1001/archpsyc.1984.01790120037006.CrossRefPubMed
39.
go back to reference Murphy GE, Carny RM, Knesevich MA, Wetzel RD, Whitworth P: Cognitive behavior therapy, relaxation training and tricyclic antidepressant medication in the treatment of depression. Psychol Rep. 1995, 77 (2): 403-420. 10.2466/pr0.1995.77.2.403.CrossRefPubMed Murphy GE, Carny RM, Knesevich MA, Wetzel RD, Whitworth P: Cognitive behavior therapy, relaxation training and tricyclic antidepressant medication in the treatment of depression. Psychol Rep. 1995, 77 (2): 403-420. 10.2466/pr0.1995.77.2.403.CrossRefPubMed
40.
go back to reference Rush AJ, Beck AT, Kovacs M, Hollon SD: Cognitive therapy and research. Comparative efficacy of cognitive therapy and pharmocotherapy in the treatment of depressed outpatients. 1977, 17-37. Rush AJ, Beck AT, Kovacs M, Hollon SD: Cognitive therapy and research. Comparative efficacy of cognitive therapy and pharmocotherapy in the treatment of depressed outpatients. 1977, 17-37.
41.
go back to reference Strauman TJ, Vieth AZ, Merrill KA, Kolden GG, Woods TE, Klein MH, et al: Self-system therapy as an intervention for self-regulatory dysfunction in depression: a randomized comparison with cognitive therapy. J Consult Clin Psychol. 2006, 74: 367-376.CrossRefPubMed Strauman TJ, Vieth AZ, Merrill KA, Kolden GG, Woods TE, Klein MH, et al: Self-system therapy as an intervention for self-regulatory dysfunction in depression: a randomized comparison with cognitive therapy. J Consult Clin Psychol. 2006, 74: 367-376.CrossRefPubMed
42.
go back to reference Teri L, Lewinsohn PM: Individual and group treatment of unipolar depression: comparison of treatment outcome and identification of predictors of succesful treatment outcome. Behav Ther. 1986, 7: 215-228.CrossRef Teri L, Lewinsohn PM: Individual and group treatment of unipolar depression: comparison of treatment outcome and identification of predictors of succesful treatment outcome. Behav Ther. 1986, 7: 215-228.CrossRef
43.
go back to reference Watson JC, Gordon LB, Stermac L, Kalogerakos F, Steckley P: Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol. 2003, 71: 773-781.CrossRefPubMed Watson JC, Gordon LB, Stermac L, Kalogerakos F, Steckley P: Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol. 2003, 71: 773-781.CrossRefPubMed
44.
go back to reference Wilson PH: Combined pharmacological and behavioural treatment of depression. Behav Res Ther. 1982, 20: 173-184. 10.1016/0005-7967(82)90116-4.CrossRefPubMed Wilson PH: Combined pharmacological and behavioural treatment of depression. Behav Res Ther. 1982, 20: 173-184. 10.1016/0005-7967(82)90116-4.CrossRefPubMed
45.
go back to reference Wilson PH, Goldin JC, Charbonneaupowis M: Cognitive therapy and research. Comparative efficacy of behavioral and cognitive treatments of depression. 1983, 111-124. 7 Wilson PH, Goldin JC, Charbonneaupowis M: Cognitive therapy and research. Comparative efficacy of behavioral and cognitive treatments of depression. 1983, 111-124. 7
46.
go back to reference Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, et al: Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry. 2005, 162: 1158-1164. 10.1176/appi.ajp.162.6.1158.CrossRefPubMed Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, et al: Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry. 2005, 162: 1158-1164. 10.1176/appi.ajp.162.6.1158.CrossRefPubMed
47.
go back to reference Zettle RD, Haflich JL, Reynolds RA: Responsivity to cognitive therapy as a function of treatment format and client personality dimensions. J Clin Psychol. 1992, 48: 787-797. 10.1002/1097-4679(199211)48:6<787::AID-JCLP2270480613>3.0.CO;2-D.CrossRefPubMed Zettle RD, Haflich JL, Reynolds RA: Responsivity to cognitive therapy as a function of treatment format and client personality dimensions. J Clin Psychol. 1992, 48: 787-797. 10.1002/1097-4679(199211)48:6<787::AID-JCLP2270480613>3.0.CO;2-D.CrossRefPubMed
48.
go back to reference Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967, 6: 278-296. 10.1111/j.2044-8260.1967.tb00530.x.CrossRefPubMed Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967, 6: 278-296. 10.1111/j.2044-8260.1967.tb00530.x.CrossRefPubMed
49.
go back to reference Zimmerman M, Posternak MA, Chelminski I: Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res. 2004, 38: 577-582. 10.1016/j.jpsychires.2004.03.007.CrossRefPubMed Zimmerman M, Posternak MA, Chelminski I: Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res. 2004, 38: 577-582. 10.1016/j.jpsychires.2004.03.007.CrossRefPubMed
50.
go back to reference Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, et al: The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol. 2006, 16: 601-611. 10.1016/j.euroneuro.2006.04.008.CrossRefPubMedPubMedCentral Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, et al: The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol. 2006, 16: 601-611. 10.1016/j.euroneuro.2006.04.008.CrossRefPubMedPubMedCentral
51.
go back to reference Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, et al: Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007, 164: 739-752. 10.1176/appi.ajp.164.5.739.CrossRefPubMed Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, et al: Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007, 164: 739-752. 10.1176/appi.ajp.164.5.739.CrossRefPubMed
52.
go back to reference van der Lem R, van der Wee NJ, Van VT, Zitman FG: Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychother Psychosom. 2012, 81: 226-234. 10.1159/000330890.CrossRefPubMed van der Lem R, van der Wee NJ, Van VT, Zitman FG: Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychother Psychosom. 2012, 81: 226-234. 10.1159/000330890.CrossRefPubMed
53.
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571. 10.1001/archpsyc.1961.01710120031004.CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571. 10.1001/archpsyc.1961.01710120031004.CrossRefPubMed
54.
go back to reference Leonard KL: Is patient satisfaction sensitive to changes in the quality of care? An exploitation of the Hawthorne effect. J Health Econ. 2008, 27: 444-459. 10.1016/j.jhealeco.2007.07.004.CrossRefPubMed Leonard KL: Is patient satisfaction sensitive to changes in the quality of care? An exploitation of the Hawthorne effect. J Health Econ. 2008, 27: 444-459. 10.1016/j.jhealeco.2007.07.004.CrossRefPubMed
55.
go back to reference Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006, 163: 28-40. 10.1176/appi.ajp.163.1.28.CrossRefPubMed Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006, 163: 28-40. 10.1176/appi.ajp.163.1.28.CrossRefPubMed
56.
go back to reference Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991, 59: 12-19.CrossRefPubMed Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991, 59: 12-19.CrossRefPubMed
Metadata
Title
The generalizability of psychotherapy efficacy trials in major depressive disorder: an analysis of the influence of patient selection in efficacy trials on symptom outcome in daily practice
Authors
Rosalind van der Lem
Wouter WH de Wever
Nic JA van der Wee
Tineke van Veen
Pim Cuijpers
Frans G Zitman
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2012
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-12-192

Other articles of this Issue 1/2012

BMC Psychiatry 1/2012 Go to the issue